Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs Clear Secure Inc (YOU) Price & Performance

Biogen IncTrade
Clear Secure IncTrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Clear Secure Inc — how do they compare? Biogen Inc trades at $191.4 (market cap $30.86B), while Clear Secure Inc trades at $54.42 (market cap $5.35B). The key difference: Biogen Inc is far larger — about 5.8× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.13% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBYOU
Market Cap
$30.86B$5.35B
Sector
HealthTechnology
52-Week High
$216.63$62.36
52-Week Low
$122.68$28.84
Enterprise Value
$33.14B$4.66B
Dividend Yield
1.13%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About Clear Secure Inc

Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.

Read more on YOU